BOEHRINGER INGELHEIM INTERNATIONAL GMBH;Zealand Pharma A/S
发明人:
申请号:
IL24479516
公开号:
IL244795A
申请日:
2016.03.28
申请国别(地区):
IL
年份:
2020
代理人:
摘要:
The invention provides materials and methods for the treatment of obesity and excess weight, diabetes, and other associated metabolic disorders. In particular, the invention provides novel acylated glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.